Segment disclosures

Company overview

ALERE INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

40 dimension combinations 591 retained observations 30 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Consumer Diagnostics

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=alr:ConsumerDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3028848000 USD20131105Open filing evidence
2013-01-01 – 2013-09-3076846000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3025448000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3047998000 USD20130808Open filing evidence
2012-07-01 – 2012-09-3024896000 USD20131105Open filing evidence
2012-01-01 – 2012-09-3068701000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3021817000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3043805000 USD20130808Open filing evidence

Operating Segments · Health Information Solutions

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthInformationSolutionsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30134233000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30403215000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30134775000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30268982000 USD20130808Open filing evidence
2012-07-01 – 2012-09-30135078000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30404452000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30138590000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30269374000 USD20130808Open filing evidence

Operating Segments · Professional Diagnostics

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30590801000 USD20131105Open filing evidence
2013-01-01 – 2013-09-301777055000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30603762000 USD20130808Open filing evidence
2013-01-01 – 2013-06-301186254000 USD20130808Open filing evidence
2012-07-01 – 2012-09-30531442000 USD20131105Open filing evidence
2012-01-01 – 2012-09-301589909000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30540110000 USD20130808Open filing evidence
2012-01-01 – 2012-06-301058467000 USD20130808Open filing evidence

Cardiology · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:CardiologyMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-30109661000 RestatedUSD20150528Open filing evidence
2014-01-01 – 2014-09-30333077000 RestatedUSD20150528Open filing evidence
2014-04-01 – 2014-06-30101783000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30223416000 USD20140806Open filing evidence
2014-01-01 – 2014-03-31121633000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31463281000 USD20140303Open filing evidence
2013-07-01 – 2013-09-30115677000 RestatedUSD20150528Open filing evidence
2013-01-01 – 2013-09-30348902000 RestatedUSD20150528Open filing evidence
2013-04-01 – 2013-06-30118436000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30233369000 USD20140806Open filing evidence
2013-01-01 – 2013-03-31114933000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31503534000 USD20140303Open filing evidence
2011-01-01 – 2011-12-31518746000 USD20140303Open filing evidence

Cardiology · Professional Diagnostics

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:CardiologyMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30116281000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30349650000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30118436000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30233369000 USD20130808Open filing evidence
2013-01-01 – 2013-03-31114933000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31503534000 USD20130301Open filing evidence
2012-07-01 – 2012-09-30122372000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30386795000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30125597000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30264423000 USD20130808Open filing evidence
2012-01-01 – 2012-03-31138826000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31518746000 USD20130301Open filing evidence
2011-07-01 – 2011-09-30127943000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30390652000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31488497000 USD20130301Open filing evidence

Cardiometabolic · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:CardiometabolicMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31442742000 RestatedUSD20150528Open filing evidence
2013-01-01 – 2013-12-31462725000 RestatedUSD20150528Open filing evidence
2012-01-01 – 2012-12-31503534000 USD20150528Open filing evidence

Cardiometabolic · Professional Diagnostics Business Segment · Reportable Subsegments

Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ProductOrServiceAxis=alr:CardiometabolicMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-30139840000 USD20170803Open filing evidence
2017-01-01 – 2017-06-30265017000 USD20170803Open filing evidence
2017-01-01 – 2017-03-31125176000 USD20170614Open filing evidence
2016-01-01 – 2016-12-31622468000 USD20170605Open filing evidence
2016-07-02 – 2016-09-30188731000 USD20161104Open filing evidence
2016-01-01 – 2016-09-30587289000 USD20161104Open filing evidence
2016-04-01 – 2016-06-30167378000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-30327041000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-31159663000 RestatedUSD20170614Open filing evidence
2015-01-01 – 2015-12-31703553000 RestatedUSD20170605Open filing evidence
2015-07-01 – 2015-09-30208979000 RestatedUSD20161104Open filing evidence
2015-01-10 – 2015-09-30621588000 USD20161104Open filing evidence
2015-01-01 – 2015-09-30624823000 USD20151109Open filing evidence
2015-04-01 – 2015-06-30211672000 RestatedUSD20160906Open filing evidence
2015-01-10 – 2015-06-30412608000 USD20160906Open filing evidence
2015-01-01 – 2015-06-30416504000 USD20150806Open filing evidence
2015-01-10 – 2015-03-31200936000 USD20160817Open filing evidence
2015-01-01 – 2015-03-31202843000 USD20150528Open filing evidence
2014-01-01 – 2014-12-31725423000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-30208248000 USD20151109Open filing evidence
2014-01-01 – 2014-09-30631452000 USD20151109Open filing evidence
2014-04-01 – 2014-06-30209241000 USD20150806Open filing evidence
2014-01-01 – 2014-06-30423204000 USD20150806Open filing evidence
2014-01-01 – 2014-03-31213963000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31858781000 USD20160808Open filing evidence

Condition And Case Management · Health Management Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:ConditionAndCaseManagementMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-3048356000 USD20141107Open filing evidence
2014-01-01 – 2014-09-30145215000 USD20141107Open filing evidence
2014-04-01 – 2014-06-3048527000 USD20140806Open filing evidence
2014-01-01 – 2014-06-3097846000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3149319000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31215160000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3055992000 USD20141107Open filing evidence
2013-01-01 – 2013-09-30161475000 USD20141107Open filing evidence
2013-04-01 – 2013-06-3052578000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30106704000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3154126000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31218378000 USD20140303Open filing evidence
2011-01-01 – 2011-12-31237938000 USD20140303Open filing evidence

Diabetes · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:DiabetesMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31197476000 USD20150528Open filing evidence
2014-07-01 – 2014-09-3049477000 USD20150528Open filing evidence
2014-01-01 – 2014-09-30151425000 USD20150528Open filing evidence
2014-04-01 – 2014-06-3051227000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30101948000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3150721000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31225488000 USD20150528Open filing evidence
2013-07-01 – 2013-09-3053150000 USD20150528Open filing evidence
2013-01-01 – 2013-09-30178138000 USD20150528Open filing evidence
2013-04-01 – 2013-06-3074905000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30124988000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3150083000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31144441000 USD20150528Open filing evidence
2011-01-01 – 2011-12-3114960000 USD20140303Open filing evidence

Diabetes · Professional Diagnostics

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:DiabetesMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3053150000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30178138000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3074905000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30124988000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3150083000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31144441000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3035670000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30100628000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3036797000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3064958000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3128161000 USD20130509Open filing evidence
2011-01-01 – 2011-12-3114960000 USD20130301Open filing evidence

Disease And Case Management · Health Management

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:DiseaseAndCaseManagementMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3056554000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30163258000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3052578000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30106704000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3154126000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31218378000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3057383000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30165277000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3054512000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30107894000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3153380000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31237938000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3059441000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30182118000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31281563000 USD20130301Open filing evidence

Infectious Disease · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:InfectiousDiseaseMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31711369000 RestatedUSD20150528Open filing evidence
2014-07-01 – 2014-09-30177955000 RestatedUSD20150528Open filing evidence
2014-01-01 – 2014-09-30507866000 RestatedUSD20150528Open filing evidence
2014-04-01 – 2014-06-30165641000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30329671000 USD20140806Open filing evidence
2014-01-01 – 2014-03-31164030000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31721754000 RestatedUSD20150528Open filing evidence
2013-07-01 – 2013-09-30172739000 USD20150528Open filing evidence
2013-01-01 – 2013-09-30520289000 USD20150528Open filing evidence
2013-04-01 – 2013-06-30157706000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30347550000 USD20140806Open filing evidence
2013-01-01 – 2013-03-31189844000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31615950000 USD20150528Open filing evidence
2011-01-01 – 2011-12-31564983000 USD20140303Open filing evidence

Infectious Disease · Professional Diagnostics Business Segment · Reportable Subsegments

Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ProductOrServiceAxis=alr:InfectiousDiseaseMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-30166544000 USD20170803Open filing evidence
2017-01-01 – 2017-06-30389478000 USD20170803Open filing evidence
2017-01-01 – 2017-03-31222934000 USD20170614Open filing evidence
2016-01-01 – 2016-12-31776153000 USD20170605Open filing evidence
2016-07-02 – 2016-09-30183375000 USD20161104Open filing evidence
2016-01-01 – 2016-09-30556777000 USD20161104Open filing evidence
2016-04-01 – 2016-06-30189384000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-30381339000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-31191956000 RestatedUSD20170614Open filing evidence
2015-01-01 – 2015-12-31710178000 RestatedUSD20170605Open filing evidence
2015-07-01 – 2015-09-30164822000 RestatedUSD20161104Open filing evidence
2015-01-10 – 2015-09-30523059000 USD20161104Open filing evidence
2015-01-01 – 2015-09-30519145000 USD20151109Open filing evidence
2015-04-01 – 2015-06-30172834000 RestatedUSD20160906Open filing evidence
2015-01-10 – 2015-06-30358236000 USD20160906Open filing evidence
2015-01-01 – 2015-06-30355386000 USD20150806Open filing evidence
2015-01-10 – 2015-03-31185402000 USD20160817Open filing evidence
2015-01-01 – 2015-03-31178756000 USD20150528Open filing evidence
2014-01-01 – 2014-12-31723715000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-30184018000 USD20151109Open filing evidence
2014-01-01 – 2014-09-30526632000 USD20151109Open filing evidence
2014-04-01 – 2014-06-30175001000 USD20150806Open filing evidence
2014-01-01 – 2014-06-30342614000 USD20150806Open filing evidence
2014-01-01 – 2014-03-31167613000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31729836000 USD20160808Open filing evidence

Infectious Disease · Professional Diagnostics

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:InfectiousDiseaseMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30172739000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30520289000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30157706000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30347550000 USD20130808Open filing evidence
2013-01-01 – 2013-03-31189844000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31615950000 USD20130301Open filing evidence
2012-07-01 – 2012-09-30136561000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30425398000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30137821000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30288837000 USD20130808Open filing evidence
2012-01-01 – 2012-03-31151016000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31564983000 USD20130301Open filing evidence
2011-07-01 – 2011-09-30142639000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30405559000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31437709000 USD20130301Open filing evidence

Other Product · Patient Self Testing Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductMember;us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-3120317000 USD20150528Open filing evidence
2013-01-01 – 2013-12-3120728000 USD20150528Open filing evidence
2012-01-01 – 2012-12-3119397000 USD20150528Open filing evidence

Other Products And Service · Patient Self Testing Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductsAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-304860000 USD20150528Open filing evidence
2014-01-01 – 2014-09-3015562000 USD20150528Open filing evidence
2013-07-01 – 2013-09-304578000 USD20150528Open filing evidence
2013-01-01 – 2013-09-3015369000 USD20150528Open filing evidence

Other Products And Service · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductsAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31342574000 USD20150528Open filing evidence
2014-07-01 – 2014-09-3084501000 USD20150528Open filing evidence
2014-01-01 – 2014-09-30252303000 USD20150528Open filing evidence
2014-04-01 – 2014-06-3094750000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30167802000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3173052000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31321495000 USD20150528Open filing evidence
2013-07-01 – 2013-09-3078607000 USD20150528Open filing evidence
2013-01-01 – 2013-09-30235992000 USD20150528Open filing evidence
2013-04-01 – 2013-06-3082666000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30157385000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3174719000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31314030000 USD20150528Open filing evidence
2011-01-01 – 2011-12-31250274000 USD20140303Open filing evidence

Other Products And Service · Professional Diagnostics Business Segment · Reportable Subsegments

Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductsAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-3035123000 USD20170803Open filing evidence
2017-01-01 – 2017-06-3068050000 USD20170803Open filing evidence
2017-01-01 – 2017-03-3132928000 USD20170614Open filing evidence
2016-01-01 – 2016-12-31140426000 USD20170605Open filing evidence
2016-07-02 – 2016-09-3032550000 USD20161104Open filing evidence
2016-01-01 – 2016-09-30102411000 USD20161104Open filing evidence
2016-04-01 – 2016-06-3036413000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-3069795000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-3133382000 RestatedUSD20170614Open filing evidence
2015-01-01 – 2015-12-31192321000 RestatedUSD20170605Open filing evidence
2015-07-01 – 2015-09-3045350000 RestatedUSD20161104Open filing evidence
2015-01-10 – 2015-09-30147511000 USD20161104Open filing evidence
2015-01-01 – 2015-09-30147512000 USD20151109Open filing evidence
2015-04-01 – 2015-06-3051031000 USD20160906Open filing evidence
2015-01-10 – 2015-06-30102164000 USD20160906Open filing evidence
2015-01-01 – 2015-06-30102163000 USD20150806Open filing evidence
2015-01-10 – 2015-03-3151132000 USD20160817Open filing evidence
2015-01-01 – 2015-03-3151132000 USD20150528Open filing evidence
2014-01-01 – 2014-12-31255076000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-3065183000 USD20151109Open filing evidence
2014-01-01 – 2014-09-30190986000 USD20151109Open filing evidence
2014-04-01 – 2014-06-3065187000 USD20150806Open filing evidence
2014-01-01 – 2014-06-30125803000 USD20150806Open filing evidence
2014-01-01 – 2014-03-3160616000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31262814000 USD20160808Open filing evidence

Other Products And Service · Professional Diagnostics

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductsAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3078607000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30235992000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3082666000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30157385000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3174719000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31314030000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3078077000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30230519000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3076736000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30152442000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3175706000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31250274000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3062172000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30176206000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31214387000 USD20130301Open filing evidence

Other Products · Patient Self Testing Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:OtherProductsMember;us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-3120317000 USD20150305Open filing evidence
2013-01-01 – 2013-12-3120728000 USD20150305Open filing evidence
2012-01-01 – 2012-12-3119635000 USD20150305Open filing evidence

Patient Self Testing Services · Health Management Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:PatientSelfTestingServicesMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-3030185000 USD20141107Open filing evidence
2014-01-01 – 2014-09-3086799000 USD20141107Open filing evidence
2014-04-01 – 2014-06-3029430000 USD20140806Open filing evidence
2014-01-01 – 2014-06-3056614000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3127184000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31102919000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3027025000 USD20141107Open filing evidence
2013-01-01 – 2013-09-3077437000 USD20141107Open filing evidence
2013-04-01 – 2013-06-3025711000 USD20140806Open filing evidence
2013-01-01 – 2013-06-3050412000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3124701000 USD20140506Open filing evidence
2012-01-01 – 2012-12-3192151000 USD20140303Open filing evidence
2011-01-01 – 2011-12-3177421000 USD20140303Open filing evidence

Patient Self Testing Services · Health Management

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:PatientSelfTestingServicesMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3027025000 USD20131105Open filing evidence
2013-01-01 – 2013-09-3077437000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3025711000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3050412000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3124701000 USD20130509Open filing evidence
2012-01-01 – 2012-12-3192151000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3024269000 USD20131105Open filing evidence
2012-01-01 – 2012-09-3068074000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3023198000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3043805000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3120607000 USD20130509Open filing evidence
2011-01-01 – 2011-12-3177421000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3017554000 USD20121108Open filing evidence
2011-01-01 – 2011-09-3060529000 USD20121108Open filing evidence
2010-01-01 – 2010-12-3187003000 USD20130301Open filing evidence

Patient Self Testing Services · Patient Self Testing Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:PatientSelfTestingServicesMember;us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31116779000 USD20150528Open filing evidence
2014-07-01 – 2014-09-3030185000 USD20150528Open filing evidence
2014-01-01 – 2014-09-3086799000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31102919000 USD20150528Open filing evidence
2013-07-01 – 2013-09-3027025000 USD20150528Open filing evidence
2013-01-01 – 2013-09-3077437000 USD20150528Open filing evidence
2012-01-01 – 2012-12-3190088000 USD20150528Open filing evidence

Toxicology · Professional Diagnostics Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:ToxicologyMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31627755000 USD20150528Open filing evidence
2014-07-01 – 2014-09-30161940000 USD20150528Open filing evidence
2014-01-01 – 2014-09-30478514000 USD20150528Open filing evidence
2014-04-01 – 2014-06-30164677000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30316574000 USD20140806Open filing evidence
2014-01-01 – 2014-03-31151897000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31631244000 RestatedUSD20150528Open filing evidence
2013-07-01 – 2013-09-30166536000 USD20150528Open filing evidence
2013-01-01 – 2013-09-30479986000 RestatedUSD20150528Open filing evidence
2013-04-01 – 2013-06-30165884000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30314933000 USD20140806Open filing evidence
2013-01-01 – 2013-03-31149049000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31588744000 RestatedUSD20150528Open filing evidence
2011-01-01 – 2011-12-31387209000 USD20140303Open filing evidence

Toxicology · Professional Diagnostics Business Segment · Reportable Subsegments

Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ProductOrServiceAxis=alr:ToxicologyMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-30159871000 USD20170803Open filing evidence
2017-01-01 – 2017-06-30310508000 USD20170803Open filing evidence
2017-01-01 – 2017-03-31150637000 USD20170614Open filing evidence
2016-01-01 – 2016-12-31608635000 USD20170605Open filing evidence
2016-07-02 – 2016-09-30155871000 USD20161104Open filing evidence
2016-01-01 – 2016-09-30460849000 USD20161104Open filing evidence
2016-04-01 – 2016-06-30158196000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-30304979000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-31146783000 USD20170614Open filing evidence
2015-01-01 – 2015-12-31618362000 RestatedUSD20170605Open filing evidence
2015-07-01 – 2015-09-30162571000 USD20161104Open filing evidence
2015-01-10 – 2015-09-30468822000 USD20161104Open filing evidence
2015-01-01 – 2015-09-30468822000 USD20151109Open filing evidence
2015-04-01 – 2015-06-30157495000 USD20160906Open filing evidence
2015-01-10 – 2015-06-30306251000 USD20160906Open filing evidence
2015-01-01 – 2015-06-30306251000 USD20150806Open filing evidence
2015-01-10 – 2015-03-31148756000 USD20160817Open filing evidence
2015-01-01 – 2015-03-31148756000 USD20150528Open filing evidence
2014-01-01 – 2014-12-31644621000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-30166381000 USD20151109Open filing evidence
2014-01-01 – 2014-09-30491561000 USD20151109Open filing evidence
2014-04-01 – 2014-06-30169647000 USD20150806Open filing evidence
2014-01-01 – 2014-06-30325180000 USD20150806Open filing evidence
2014-01-01 – 2014-03-31155533000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31644527000 USD20160808Open filing evidence

Toxicology · Professional Diagnostics

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:ToxicologyMember;us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30166536000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30481469000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30165884000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30314933000 USD20130808Open filing evidence
2013-01-01 – 2013-03-31149049000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31587261000 USD20130301Open filing evidence
2012-07-01 – 2012-09-30156074000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30437736000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30159922000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30281662000 USD20130808Open filing evidence
2012-01-01 – 2012-03-31121740000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31387209000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3093497000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30267834000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31300125000 USD20130301Open filing evidence

Wellness · Health Management Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:WellnessMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-3021546000 USD20141107Open filing evidence
2014-01-01 – 2014-09-3070030000 USD20141107Open filing evidence
2014-04-01 – 2014-06-3023534000 USD20140806Open filing evidence
2014-01-01 – 2014-06-3048484000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3124950000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31101642000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3022223000 USD20141107Open filing evidence
2013-01-01 – 2013-09-3075753000 USD20141107Open filing evidence
2013-04-01 – 2013-06-3027230000 USD20140806Open filing evidence
2013-01-01 – 2013-06-3053530000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3126300000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31104634000 USD20140303Open filing evidence
2011-01-01 – 2011-12-31104868000 USD20140303Open filing evidence

Wellness · Health Management

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:WellnessMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3022223000 USD20131105Open filing evidence
2013-01-01 – 2013-09-3075753000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3027230000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3053530000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3126300000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31104634000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3024290000 USD20131105Open filing evidence
2012-01-01 – 2012-09-3080881000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3029567000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3056591000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3127026000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31104868000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3024427000 USD20121108Open filing evidence
2011-01-01 – 2011-09-3080369000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31103343000 USD20130301Open filing evidence

Womens And Childrens Health · Health Management Business Segment

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:WomensAndChildrensHealthMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-3023769000 USD20141107Open filing evidence
2014-01-01 – 2014-09-3070308000 USD20141107Open filing evidence
2014-04-01 – 2014-06-3024324000 USD20140806Open filing evidence
2014-01-01 – 2014-06-3046539000 USD20140806Open filing evidence
2014-01-01 – 2014-03-3122215000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31113506000 USD20140303Open filing evidence
2013-07-01 – 2013-09-3028431000 USD20141107Open filing evidence
2013-01-01 – 2013-09-3086767000 USD20141107Open filing evidence
2013-04-01 – 2013-06-3029256000 USD20140806Open filing evidence
2013-01-01 – 2013-06-3058336000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3129080000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31120259000 USD20140303Open filing evidence
2011-01-01 – 2011-12-31114287000 USD20140303Open filing evidence

Womens And Childrens Health · Health Management

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=alr:WomensAndChildrensHealthMember;us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3028431000 USD20131105Open filing evidence
2013-01-01 – 2013-09-3086767000 USD20131105Open filing evidence
2013-04-01 – 2013-06-3029256000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3058336000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3129080000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31120259000 USD20130301Open filing evidence
2012-07-01 – 2012-09-3029136000 USD20131105Open filing evidence
2012-01-01 – 2012-09-3090220000 USD20131105Open filing evidence
2012-04-01 – 2012-06-3031313000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3061084000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3129771000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31114287000 USD20130301Open filing evidence
2011-07-01 – 2011-09-3028509000 USD20121108Open filing evidence
2011-01-01 – 2011-09-3085550000 USD20121108Open filing evidence
2010-01-01 – 2010-12-31126910000 USD20130301Open filing evidence

Consumer Diagnostics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:ConsumerDiagnosticsMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-3016507000 USD20170803Open filing evidence
2017-01-01 – 2017-06-3033747000 USD20170803Open filing evidence
2017-01-01 – 2017-03-3117240000 USD20170614Open filing evidence
2016-01-01 – 2016-12-3174152000 USD20170605Open filing evidence
2016-07-02 – 2016-09-3019347000 USD20161104Open filing evidence
2016-01-01 – 2016-09-3056583000 USD20161104Open filing evidence
2016-04-01 – 2016-06-3019795000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-3037237000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-3117442000 USD20170614Open filing evidence
2015-01-01 – 2015-12-3185128000 USD20170605Open filing evidence
2015-07-01 – 2015-09-3018747000 USD20161104Open filing evidence
2015-01-10 – 2015-09-3065360000 USD20161104Open filing evidence
2015-01-01 – 2015-09-3065360000 USD20151109Open filing evidence
2015-04-01 – 2015-06-3024645000 USD20160906Open filing evidence
2015-01-10 – 2015-06-3046612000 USD20160906Open filing evidence
2015-01-01 – 2015-06-3046613000 USD20150806Open filing evidence
2015-01-10 – 2015-03-3121968000 USD20160817Open filing evidence
2015-01-01 – 2015-03-3121968000 USD20150528Open filing evidence
2014-01-01 – 2014-12-3189087000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-3021198000 RestatedUSD20151109Open filing evidence
2014-01-01 – 2014-09-3065218000 RestatedUSD20151109Open filing evidence
2014-04-01 – 2014-06-3021718000 RestatedUSD20150806Open filing evidence
2014-01-01 – 2014-06-3044020000 RestatedUSD20150806Open filing evidence
2014-01-01 – 2014-03-3122302000 RestatedUSD20150528Open filing evidence
2013-01-01 – 2013-12-3185450000 RestatedUSD20160808Open filing evidence
2013-07-01 – 2013-09-3028848000 USD20150528Open filing evidence
2013-01-01 – 2013-09-3076846000 USD20150528Open filing evidence
2013-04-01 – 2013-06-3025448000 USD20140806Open filing evidence
2013-01-01 – 2013-06-3047998000 USD20140806Open filing evidence
2013-01-01 – 2013-03-3122550000 USD20140506Open filing evidence
2012-01-01 – 2012-12-3193511000 USD20150528Open filing evidence
2012-07-01 – 2012-09-3024896000 USD20121108Open filing evidence
2012-01-01 – 2012-09-3068701000 USD20121108Open filing evidence
2012-04-01 – 2012-06-3021817000 USD20120808Open filing evidence
2012-01-01 – 2012-06-3043805000 USD20120808Open filing evidence
2012-01-01 – 2012-03-3121988000 USD20130509Open filing evidence
2011-01-01 – 2011-12-3195504000 USD20140303Open filing evidence
2011-07-01 – 2011-09-3025886000 USD20121108Open filing evidence
2011-01-01 – 2011-09-3072014000 USD20121108Open filing evidence
2011-04-01 – 2011-06-3022539000 USD20120808Open filing evidence
2011-01-01 – 2011-06-3046128000 USD20120808Open filing evidence
2011-01-01 – 2011-03-3123589000 USD20120510Open filing evidence
2010-01-01 – 2010-12-3197036000 USD20130301Open filing evidence
2010-07-01 – 2010-09-3022266000 USD20111108Open filing evidence
2010-01-01 – 2010-09-3072288000 USD20111108Open filing evidence
2010-04-01 – 2010-06-3023693000 USD20110808Open filing evidence
2010-01-01 – 2010-06-3050022000 USD20110808Open filing evidence
2009-01-01 – 2009-12-31137183000 USD20120229Open filing evidence

Health Information Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:HealthInformationSolutionsMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-31134207000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31535422000 USD20130301Open filing evidence
2012-01-01 – 2012-03-31130784000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31534514000 USD20130301Open filing evidence
2010-01-01 – 2010-12-31598819000 USD20130301Open filing evidence

Health Management Business Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementBusinessSegmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-30123856000 USD20141107Open filing evidence
2014-01-01 – 2014-09-30372352000 USD20141107Open filing evidence
2014-04-01 – 2014-06-30125815000 USD20140806Open filing evidence
2014-01-01 – 2014-06-30249483000 USD20140806Open filing evidence
2014-01-01 – 2014-03-31123668000 USD20140506Open filing evidence
2013-01-01 – 2013-12-31533227000 USD20140303Open filing evidence
2013-07-01 – 2013-09-30133671000 USD20141107Open filing evidence
2013-01-01 – 2013-09-30401432000 USD20141107Open filing evidence
2013-04-01 – 2013-06-30134775000 USD20140806Open filing evidence
2013-01-01 – 2013-06-30268982000 USD20140806Open filing evidence
2013-01-01 – 2013-03-31134207000 USD20140506Open filing evidence
2012-01-01 – 2012-12-31535422000 USD20140303Open filing evidence
2011-01-01 – 2011-12-31534514000 USD20140303Open filing evidence

Health Management

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:HealthManagementMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30134233000 USD20131105Open filing evidence
2013-01-01 – 2013-09-30403215000 USD20131105Open filing evidence
2013-04-01 – 2013-06-30134775000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30268982000 USD20130808Open filing evidence
2013-01-01 – 2013-03-31134207000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31535422000 USD20130301Open filing evidence
2012-07-01 – 2012-09-30135078000 USD20131105Open filing evidence
2012-01-01 – 2012-09-30404452000 USD20131105Open filing evidence
2012-04-01 – 2012-06-30138590000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30269374000 USD20130808Open filing evidence
2012-01-01 – 2012-03-31130784000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31534514000 USD20130301Open filing evidence
2011-07-01 – 2011-09-30129931000 USD20121108Open filing evidence
2011-01-01 – 2011-09-30408566000 USD20121108Open filing evidence
2011-04-01 – 2011-06-30135572000 USD20120808Open filing evidence
2011-01-01 – 2011-06-30278635000 USD20120808Open filing evidence
2011-01-01 – 2011-03-31143063000 USD20120510Open filing evidence
2010-01-01 – 2010-12-31598819000 USD20130301Open filing evidence
2010-07-01 – 2010-09-30152894000 USD20111108Open filing evidence
2010-01-01 – 2010-09-30451182000 USD20111108Open filing evidence
2010-04-01 – 2010-06-30149756000 USD20110808Open filing evidence
2010-01-01 – 2010-06-30298288000 USD20110808Open filing evidence
2009-01-01 – 2009-12-31521947000 USD20120229Open filing evidence

Other Non Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:OtherNonSegmentMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-3036806000 USD20170803Open filing evidence
2017-01-01 – 2017-06-3073465000 USD20170803Open filing evidence
2017-01-01 – 2017-03-3136659000 USD20170614Open filing evidence
2016-01-01 – 2016-12-31142503000 USD20170605Open filing evidence
2016-04-01 – 2016-06-3036605000 USD20170803Open filing evidence
2016-01-01 – 2016-06-3071591000 USD20170803Open filing evidence
2016-01-01 – 2016-03-3134985000 USD20170614Open filing evidence
2015-01-01 – 2015-12-31129096000 USD20170605Open filing evidence
2014-01-01 – 2014-12-31118029000 USD20170605Open filing evidence

Patient Self Testing Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingSegmentMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31137096000 USD20150528Open filing evidence
2014-07-01 – 2014-09-3035045000 USD20150528Open filing evidence
2014-01-01 – 2014-09-30102361000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31123647000 USD20150528Open filing evidence
2013-07-01 – 2013-09-3031603000 USD20150528Open filing evidence
2013-01-01 – 2013-09-3092806000 USD20150528Open filing evidence
2012-01-01 – 2012-12-31109485000 RestatedUSD20150528Open filing evidence

Patient Self Testing Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:PatientSelfTestingServicesMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31137096000 USD20150528Open filing evidence
2013-01-01 – 2013-12-31123647000 USD20150528Open filing evidence
2012-01-01 – 2012-12-31109485000 RestatedUSD20150528Open filing evidence

Professional Diagnostics Business Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsBusinessSegmentMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-30504359000 USD20170803Open filing evidence
2017-01-01 – 2017-06-301038676000 USD20170803Open filing evidence
2017-01-01 – 2017-03-31534317000 USD20170614Open filing evidence
2016-01-01 – 2016-12-312159680000 USD20170605Open filing evidence
2016-07-02 – 2016-09-30563007000 USD20161104Open filing evidence
2016-01-01 – 2016-09-301715068000 USD20161104Open filing evidence
2016-04-01 – 2016-06-30553904000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-06-301088416000 RestatedUSD20170803Open filing evidence
2016-01-01 – 2016-03-31534513000 RestatedUSD20170614Open filing evidence
2015-01-01 – 2015-12-312241391000 RestatedUSD20170605Open filing evidence
2015-07-01 – 2015-09-30585021000 RestatedUSD20161104Open filing evidence
2015-01-10 – 2015-09-301774671000 USD20161104Open filing evidence
2015-01-01 – 2015-09-301773993000 USD20151109Open filing evidence
2015-04-01 – 2015-06-30598726000 RestatedUSD20160906Open filing evidence
2015-01-10 – 2015-06-301189651000 USD20160906Open filing evidence
2015-01-01 – 2015-06-301190696000 USD20150806Open filing evidence
2015-01-10 – 2015-03-31590924000 USD20160817Open filing evidence
2015-01-01 – 2015-03-31586185000 USD20150528Open filing evidence
2014-01-01 – 2014-12-312369885000 RestatedUSD20170605Open filing evidence
2014-07-01 – 2014-09-30628012000 RestatedUSD20151109Open filing evidence
2014-01-01 – 2014-09-301856629000 RestatedUSD20151109Open filing evidence
2014-04-01 – 2014-06-30625680000 RestatedUSD20150806Open filing evidence
2014-01-01 – 2014-06-301228617000 RestatedUSD20150806Open filing evidence
2014-01-01 – 2014-03-31602937000 RestatedUSD20150528Open filing evidence
2013-01-01 – 2013-12-312523186000 RestatedUSD20160808Open filing evidence
2013-07-01 – 2013-09-30590197000 RestatedUSD20150528Open filing evidence
2013-01-01 – 2013-09-301774824000 RestatedUSD20150528Open filing evidence
2013-04-01 – 2013-06-30599597000 RestatedUSD20140806Open filing evidence
2013-01-01 – 2013-06-301178225000 RestatedUSD20140806Open filing evidence
2013-01-01 – 2013-03-31578628000 RestatedUSD20140506Open filing evidence
2012-01-01 – 2012-12-312191375000 RestatedUSD20150528Open filing evidence
2011-01-01 – 2011-12-311736172000 RestatedUSD20140303Open filing evidence

Professional Diagnostics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=alr:ProfessionalDiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30587313000 RestatedUSD20131105Open filing evidence
2013-01-01 – 2013-09-301765538000 RestatedUSD20131105Open filing evidence
2013-04-01 – 2013-06-30599597000 RestatedUSD20130808Open filing evidence
2013-01-01 – 2013-06-301178225000 RestatedUSD20130808Open filing evidence
2013-01-01 – 2013-03-31578628000 RestatedUSD20130509Open filing evidence
2012-01-01 – 2012-12-312165216000 RestatedUSD20130301Open filing evidence
2012-07-01 – 2012-09-30528754000 RestatedUSD20131105Open filing evidence
2012-01-01 – 2012-09-301581076000 RestatedUSD20131105Open filing evidence
2012-04-01 – 2012-06-30536873000 RestatedUSD20130808Open filing evidence
2012-01-01 – 2012-06-301052322000 RestatedUSD20130808Open filing evidence
2012-01-01 – 2012-03-31515449000 RestatedUSD20130509Open filing evidence
2011-01-01 – 2011-12-311736172000 RestatedUSD20130301Open filing evidence
2011-07-01 – 2011-09-30426251000 RestatedUSD20121108Open filing evidence
2011-01-01 – 2011-09-301240251000 RestatedUSD20121108Open filing evidence
2011-04-01 – 2011-06-30404215000 RestatedUSD20120808Open filing evidence
2011-01-01 – 2011-06-30814000000 RestatedUSD20120808Open filing evidence
2011-01-01 – 2011-03-31409785000 RestatedUSD20120510Open filing evidence
2010-01-01 – 2010-12-311440718000 RestatedUSD20130301Open filing evidence
2010-07-01 – 2010-09-30359481000 RestatedUSD20111108Open filing evidence
2010-01-01 – 2010-09-301039315000 RestatedUSD20111108Open filing evidence
2010-04-01 – 2010-06-30349511000 USD20110808Open filing evidence
2010-01-01 – 2010-06-30689904000 USD20110808Open filing evidence
2009-01-01 – 2009-12-311238251000 RestatedUSD20120229Open filing evidence

Corporate And Other

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember
PeriodValueUnitFiledEvidence
2017-04-01 – 2017-06-300 USD20170803Open filing evidence
2017-01-01 – 2017-06-300 USD20170803Open filing evidence
2017-01-01 – 2017-03-310 USD20170614Open filing evidence
2016-01-01 – 2016-12-310 USD20170605Open filing evidence
2016-07-02 – 2016-09-300 USD20161104Open filing evidence
2016-01-01 – 2016-09-300 USD20161104Open filing evidence
2016-04-01 – 2016-06-300 USD20170803Open filing evidence
2016-01-01 – 2016-06-300 USD20170803Open filing evidence
2016-01-01 – 2016-03-310 USD20170614Open filing evidence
2015-01-01 – 2015-12-310 USD20170605Open filing evidence
2015-07-01 – 2015-09-300 USD20161104Open filing evidence
2015-01-10 – 2015-09-300 USD20161104Open filing evidence
2015-01-01 – 2015-09-300 USD20151109Open filing evidence
2015-04-01 – 2015-06-300 USD20160906Open filing evidence
2015-01-10 – 2015-06-300 USD20160906Open filing evidence
2015-01-01 – 2015-06-300 USD20150806Open filing evidence
2015-01-10 – 2015-03-310 USD20160817Open filing evidence
2015-01-01 – 2015-03-310 USD20150528Open filing evidence
2014-01-01 – 2014-12-310 USD20170605Open filing evidence
2014-07-01 – 2014-09-300 USD20151109Open filing evidence
2014-01-01 – 2014-09-300 USD20151109Open filing evidence
2014-04-01 – 2014-06-300 USD20150806Open filing evidence
2014-01-01 – 2014-06-300 USD20150806Open filing evidence
2014-01-01 – 2014-03-310 USD20150528Open filing evidence
2013-01-01 – 2013-12-310 USD20160808Open filing evidence
2013-07-01 – 2013-09-300 USD20150528Open filing evidence
2013-01-01 – 2013-09-300 USD20150528Open filing evidence
2013-04-01 – 2013-06-300 USD20140806Open filing evidence
2013-01-01 – 2013-06-300 USD20140806Open filing evidence
2013-01-01 – 2013-03-310 USD20140506Open filing evidence
2012-01-01 – 2012-12-310 USD20150528Open filing evidence